Ultragenyx to Host Conference Call for Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
NOVATO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that it will host a conference call …